MDMA research has been widely publicized by combat veterans, who say limited PTSD treatment options have contributed to higher military suicide rates.

The FDA declined to approve MDMA-assisted therapy, commonly known as ecstasy, as a treatment for PTSD.

The FDA this week declined to approve the use of MDMA — popularly known as Ecstasy or Molly — for MDMA-assisted therapy for treating PTSD.

The Food and Drug Administration declined to approve MDMA as the first psychedelic drug used to treat post-traumatic stress disorder.

MDMA studies suggested the psychedelic was effective, but strong opposition from a FDA advisory panel doomed Lykos Therapeutics' application.

Last month, the first psychedelic therapy treatment came before the Food and Drug Administration for a vote. It entailed using MDMA, also known as ecstasy or molly, to treat PTSD. MDMA therapy has ...

FDA rejects psychedelic MDMA as treatment for PTSD, calling for additional study Drugmaker Lykos Therapeutics said the FDA notified the company that its drug “could not be approved based on data ...

The FDA declined to approve MDMA-assisted therapy, commonly known as ecstasy, as a treatment for PTSD.

FDA rejects psychedelic MDMA as treatment for PTSD, calling for additional study MDMA is the first in a series of psychedelics that are expected to be reviewed by the FDA in coming years as part ...

WASHINGTON (AP) — Federal health regulators on Friday declined to approve the psychedelic drug MDMA as a therapy for PTSD, a major setback for groups seeking a breakthrough decision in favor of ...

FDA rejects psychedelic MDMA as treatment for PTSD, calling for additional study Drugmaker Lykos Therapeutics said the FDA notified the company that its drug “could not be approved based on data ...